Business Standard

Saturday, February 08, 2025 | 04:25 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dabur India Ltd News

Dabur reduces strategic review cycle to 3 years amidst FMCG slowdown

Home-grown FMCG major Dabur has lowered the time of its strategic vision cycle from four years to three years aiming to create a more agile organisation amid a slowdown in the FMCG space and volatile geopolitical landscape. It has engaged consulting firm McKinsey & Co to refine and align its strategies for the next three years in line with the evolving dynamics, its CEO Mohit Malhotra said in an earnings call. "This exercise has already begun, and we plan to conclude the same by the end of the fiscal year. This will enable us to capture emerging opportunities and navigate the future with sharper and more focused vision," he said. Dabur has four-year vision plans and is currently in the seventh vision cycle. "Earlier we used to have a four-year vision cycle... We feel that in this volatile and heavy-headwind macroeconomic environment and FMCG not doing so well as a sector... we require a validation of our strategies through an external consultant," he said. Malhorta further said ..

Dabur reduces strategic review cycle to 3 years amidst FMCG slowdown
Updated On : 04 Feb 2025 | 1:56 PM IST

Dabur becomes 2nd largest player in oral care in Modern Trade channels: CEO

FMCG major Dabur has become the second-largest player in the oral care segment in the modern trade channels, its chief executive officer Mohit Malhotra claimed on Monday. The company, which operates in the segment with Dabur Red Toothpaste and premium brand Meswak, ended the quarter with a 9.1 per cent growth and it believes that this segment has " huge potential". "The Gel toothpaste portfolio has received a good response, recording 50%+ y-o-y growth this quarter. Dabur oral care is now the 2nd brand in Modern Trade Pan-India," he said in the post-earnings call. "Even in modern trade, where the competitor is very strong with premium variants etc., there also we have become a number two brand now in modern trade. So, this is very encouraging for us," Malhotra added. The oral care market is led by Colgate Palmolive and FMCG major HUL is at the second spot with brands such as Pepsodent, Closeup and Ayush. "Dabur Red is doing well on the back of tailwind coming from the herbal catego

Dabur becomes 2nd largest player in oral care in Modern Trade channels: CEO
Updated On : 03 Feb 2025 | 11:40 PM IST

FMCG major Dabur to undertake price hikes in toothpaste, fruit juices

Company record net profit of Rs 522 crore, revenue rises 3.1% in Q3

FMCG major Dabur to undertake price hikes in toothpaste, fruit juices
Updated On : 30 Jan 2025 | 7:17 PM IST

Dabur India Q3FY25 results: Net profit rises 1.8% to Rs 515.82 crore

Homegrown FMCG major Dabur India Ltd on Thursday reported a 1.85 per cent increase in consolidated net profit to Rs 515.82 crore in the December quarter. The company had posted a net profit of Rs 506.44 crore in the year-ago period, Dabur India said in a regulatory filing. Its revenue from operations was up 3 per cent to Rs 3,355.25 crore during the quarter under review. It was Rs 3,255.06 crore in the corresponding quarter of the previous fiscal year. Dabur India's total expenses were at Rs 2,826.20 crore, up 3.9 per cent in the December quarter. Total income of Dabur, which includes other income, was at Rs 3,483.28 crore, up 3 per cent. Shares of Dabur India Ltd were trading at Rs 535.10 on the BSE after lunch session, up 3.27 per cent from the previous close.

Dabur India Q3FY25 results: Net profit rises 1.8% to Rs 515.82 crore
Updated On : 30 Jan 2025 | 3:58 PM IST

Dabur vs Tata in court as battle over 'schezwan chutney' trademark hots up

Schezwan Chutney: Brand name or generic product? Delhi High Court is hearing arguments from Dabur India and Tata Consumer-owned Capital Foods

Dabur vs Tata in court as battle over 'schezwan chutney' trademark hots up
Updated On : 14 Jan 2025 | 5:33 PM IST

FMCG index gains over 1% in weak market; HUL, Marico, Colgate rally upto 5%

The upcoming Union Budget is the near-term catalyst, where central government actions to revive consumption cycle would be key.

FMCG index gains over 1% in weak market; HUL, Marico, Colgate rally upto 5%
Updated On : 09 Jan 2025 | 1:17 PM IST

These 5 Nifty Next 50 stocks can rally up to 17%; suggest tech charts

Technical chart shows that the Nifty Next 50 index looks weak and could slide towards 58,670 - implying an over 11% fall from present levels, whereas on the upside can jump by 6% to 70,200 levels.

These 5 Nifty Next 50 stocks can rally up to 17%; suggest tech charts
Updated On : 09 Jan 2025 | 12:20 PM IST

FMCG major Dabur faces continued margin pressures, growth challenges

Many analysts have downgraded growth and margin expectations in response to the update

FMCG major Dabur faces continued margin pressures, growth challenges
Updated On : 06 Jan 2025 | 8:22 PM IST

F&O Market: Union Bank, Dabur see short build-up as Nifty tumbles 300pts

Union Bank stock futures plunged nearly 8% on the back of 54% increase in OI. On the other hand, Dr. Lal Path Labs and Metropolis Health witnessed long build-up on Monday; shows derivatives data.

F&O Market: Union Bank, Dabur see short build-up as Nifty tumbles 300pts
Updated On : 06 Jan 2025 | 12:41 PM IST

Dabur expects muted revenue growth in Q3; Marico upbeat on top line growth

The maker of Hajmola candy and Real fruit juice said rural consumption continued to be resilient and grow faster than urban in the third quarter

Dabur expects muted revenue growth in Q3; Marico upbeat on top line growth
Updated On : 03 Jan 2025 | 9:34 PM IST

Dabur expects single-digit revenue growth, flat operating profit in Q3FY25

Dabur expects a "low single-digit growth" in the December quarter along with a "flattish operating profit" as the homegrown FMCG major faced inflationary headwinds in some of the segments. This forced Dabur to go for "tactical price increases" and tried to mitigate the inflationary pressure through cost-efficiency initiatives partially, Dabur informed in its quarterly updates on Friday. During the October-December period, rural consumption of FMCG was resilient and continued to grow faster. Alternative channels like modern trade, e-commerce, and quick commerce continued to post strong growth, while general trade, which mainly includes neighbourhood kirna stores was still under pressure in the October-December period. In the domestic market, Dabur's HPC (home & personal care) is expected to grow in the mid to high single digits, while Health Care is expected to be 'flattish' due to the delayed winter onset. "While the Beverages portfolio is expected to report muted performance, our

Dabur expects single-digit revenue growth, flat operating profit in Q3FY25
Updated On : 03 Jan 2025 | 5:45 PM IST

Dabur sues Patanjali Ayurved over 'disparaging' Chyawanprash advertisement

The lawsuit alleges that an advertisement featuring Patanjali Ayurved founder Baba Ramdev falsely claims that only Patanjali's Chyawanprash is 'original'

Dabur sues Patanjali Ayurved over 'disparaging' Chyawanprash advertisement
Updated On : 24 Dec 2024 | 8:47 PM IST

FMCG major Dabur India's stock seems reasonably valued post correction

Dabur is expanding its premium portfolio and Total Addressable Market (TAM). The company estimates its existing portfolio, contributes less than 5 per cent of TAM

FMCG major Dabur India's stock seems reasonably valued post correction
Updated On : 16 Dec 2024 | 9:25 PM IST

FMCG woes: HUL, Dabur, Godrej Consumer risk up to 15% downside; show charts

As FMCG shares led by Godrej Consumer fell up to 11% on Monday post the volume growth concern; the Nifty FMCG index slipped below its 20-DMA after a two-week struggle; chart hints at further 4.5% dip.

FMCG woes: HUL, Dabur, Godrej Consumer risk up to 15% downside; show charts
Updated On : 09 Dec 2024 | 10:52 AM IST

Dabur faces Rs 4.42 cr customs penalty, vows to contest in appellate court

Dabur India faces a Rs 4.42 crore tax demand from Customs for IGST on imports from 2019-2024; the FMCG firm plans to appeal, citing strong merits for a favourable outcome

Dabur faces Rs 4.42 cr customs penalty, vows to contest in appellate court
Updated On : 06 Dec 2024 | 4:47 PM IST

Dabur Q2 may be a blip, price fall may provide entry to long-term investors

India revenue declined 7.6 per cent Y-o-Y, while international business grew 13 per cent Y-o-Y in constant currency (CC) terms

Dabur Q2 may be a blip, price fall may provide entry to long-term investors
Updated On : 04 Nov 2024 | 10:51 AM IST

Dabur Q2 results: Net profit falls 17% to Rs 425 crore on low urban demand

The maker of Hajmola candy and Real fruit juice, recorded a 5.5 per cent drop in net sales to Rs 3,028.6 crore from Rs 3,203.8 crore in the year ago period

Dabur Q2 results: Net profit falls 17% to Rs 425 crore on low urban demand
Updated On : 30 Oct 2024 | 8:56 PM IST

Dabur Q2 results: PAT down 17.6% to Rs 417.5 cr, revenue declines 5%

Homegrown FMCG major Dabur India Ltd on Wednesday reported a decline of 17.65 per cent in its consolidated net profit to Rs 417.52 crore in the September 2024 quarter. The company had posted a net profit of Rs 507.04 crore in the July-September quarter a year ago, Dabur India said in a regulatory filing. Its revenue from operations slipped 5.46 per cent to Rs 3,028.59 crore during the quarter under review. It was Rs 3,203.84 crore in the corresponding quarter of the previous fiscal. Dabur India's total expenses were at Rs 2,634.40 crore, down 1.31 per cent in the September quarter. "Despite a challenging demand environment marked by high food inflation and a resultant squeeze in urban demand, Dabur continued to drive consumer engagement across its key brands to end the second quarter of 2024-25 with a consolidated revenue of Rs 3,029 crore," Dabur said in its earnings statement. Shares of Dabur India Ltd settled 2.07 per cent higher at Rs 546.95 on the BSE.

Dabur Q2 results: PAT down 17.6% to Rs 417.5 cr, revenue declines 5%
Updated On : 30 Oct 2024 | 4:16 PM IST

Dabur to acquire ayurvedic product maker Sesa Care for Rs 315-325 crore

Home-grown FMCG and Ayurvedic products maker Dabur on Wednesday announced the acquisition of Sesa Care, engaged in the Ayurvedic personal care and wellness segment, at an enterprise value of Rs 315-325 crore. This new acquisition will help Dabur to expand in the Rs 900 crore ayurvedic hair oil market, the company said in a regulatory filing. It has entered into an agreement to acquire the majority 51 per cent stake from its shareholder True North (a private equity fund) for Rs 12 crore at face value. "The enterprise value is estimated to be in the range of Rs 315-325 crore, including debt of Rs 289 crore, which will be backed by the corporate guarantee of Dabur," it added. While the remaining 49 per cent shares in Sesa, there will be a share swap for the equity shares. "The share swap for the equity shares and remaining 49 per cent CRPS in Sesa will be decided at the time of filing the scheme of merger, based on the valuation reports," it said. This merger aligns with Dabur's ...

Dabur to acquire ayurvedic product maker Sesa Care for Rs 315-325 crore
Updated On : 30 Oct 2024 | 4:51 PM IST

Q2 results today: L&T, Tata Power, P&G, Dabur among 77 to post earnings

Q2FY25 company results: Aditya Birla Capital, Protean eGov Technologies, TTK Prestige, and New India Assurance will release their second-quarter results for the financial year 2024-25 on October 30

Q2 results today: L&T, Tata Power, P&G, Dabur among 77 to post earnings
Updated On : 30 Oct 2024 | 10:28 AM IST